## Core Concept
The question pertains to the management of increased intracranial pressure (ICT) and the pharmacological agents that can or cannot be used in this context. Increased ICT can result from various conditions such as traumatic brain injury, stroke, and brain tumors. Management strategies often focus on reducing cerebral edema, maintaining cerebral perfusion, and avoiding further increases in pressure.

## Why the Correct Answer is Right
Mannitol is an osmotic diuretic commonly used to reduce increased ICT. It works by creating an osmotic gradient that helps to draw water out of brain tissues, thereby reducing cerebral edema. On the other hand, certain medications can exacerbate cerebral edema or increase ICT and should be avoided or used with caution.

## Why Each Wrong Option is Incorrect
- **Option A:** Not specified, assuming a commonly used agent in increased ICT.
- **Option B:** Not specified, assuming another agent.
- **Option C:** Not specified, assuming an agent that could potentially be used.
- **Option D:**
## Clinical Pearl / High-Yield Fact
A key clinical pearl is that **dexamethasone**, a corticosteroid, can be beneficial in reducing cerebral edema associated with brain tumors but is not typically used for other causes of increased ICT like traumatic brain injury. However, **nitroglycerin** and other **nitrates** can be problematic as they can cause **cerebral vasodilation**, potentially increasing ICT.

## Correct Answer: D.